Savara Inc Impairment of Long-Lived Assets Held-for-use
Savara Inc (SVRA) reported Impairment of Long-Lived Assets Held-for-use of $510.74 thousand for the 214-month period ending 2014-03-31, per its 10-Q filed 2014-05-05.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ImpairmentOfLongLivedAssetsHeldForUse · last filed 2014-05-05
- Savara Inc impairment of long-lived assets held-for-use for the quarter ending 2012-12-31 was $102.63K.
- Savara Inc impairment of long-lived assets held-for-use for the quarter ending 2012-09-30 was $0.00.
- Savara Inc impairment of long-lived assets held-for-use for fiscal 2012 was $402.74K.
| Period end | Impairment of Long-Lived Assets Held-for-use 3 month | Impairment of Long-Lived Assets Held-for-use 6 month | Impairment of Long-Lived Assets Held-for-use 6 month as first filed | Impairment of Long-Lived Assets Held-for-use 9 month | Impairment of Long-Lived Assets Held-for-use 9 month as first filed | Impairment of Long-Lived Assets Held-for-use 12 month | Impairment of Long-Lived Assets Held-for-use 199 month | Impairment of Long-Lived Assets Held-for-use 202 month | Impairment of Long-Lived Assets Held-for-use 205 month | Impairment of Long-Lived Assets Held-for-use 208 month | Impairment of Long-Lived Assets Held-for-use 211 month | Impairment of Long-Lived Assets Held-for-use 214 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2014-03-31 | $510.74K 10-Q · filed 2014-05-05 | |||||||||||
| 2013-12-31 | $510.74K 10-K · filed 2014-03-26 | |||||||||||
| 2013-09-30 | $510.74K 10-Q · filed 2013-11-04 | |||||||||||
| 2013-06-30 | $510.74K 10-Q · filed 2013-08-05 | |||||||||||
| 2013-03-31 | $510.74K 10-Q · filed 2013-05-15 | |||||||||||
| 2012-12-31 | $102.63K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-26 | $102.63K derived: sum of 2 quarters · filed 2014-03-26 | $402.74K 10-K · filed 2014-03-26 | $510.74K 10-K · filed 2013-03-19 | ||||||||
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-04 | $300.11K 10-Q · filed 2013-11-04 | $300.00K 10-Q · filed 2012-11-05 | |||||||||
| 2012-06-30 | $300.11K 10-Q · filed 2013-08-05 | $300.00K 10-Q · filed 2012-08-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B |